<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811420496</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811420496</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Novel Mutations in the C-Terminal Region of the <italic>MECP2</italic> Gene in Tunisian Rett Syndrome Patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fendri-Kriaa</surname>
<given-names>Nourhene</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420496">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811420496"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rouissi</surname>
<given-names>Aida</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811420496">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ghorbel</surname>
<given-names>Rania</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420496">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mkaouar-Rebai</surname>
<given-names>Emna</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420496">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belguith</surname>
<given-names>Neila</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420496">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gouider-Khouja</surname>
<given-names>Naziha</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811420496">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fakhfakh</surname>
<given-names>Faiza</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420496">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883073811420496">
<label>1</label>Laboratoire de Génétique Moléculaire Humaine, Faculté de Médecine de Sfax, Université de Sfax, Tunisia</aff>
<aff id="aff2-0883073811420496">
<label>2</label>Service de Neurologie de l’enfant et de l’adolescent, Institut National de Neurologie, Tunis, Tunisia</aff>
<author-notes>
<corresp id="corresp1-0883073811420496">Nourhene Fendri-Kriaa, PhD, Faiza Fakhfakh Laboratoire de Génétique Moléculaire Humaine, Faculté de Médecine de Sfax, Avenue Magida Boulila, 3029 Sfax, Tunisia Email: <email>nourhene.fendri@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<fpage>564</fpage>
<lpage>568</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>6</month>
<year>2011</year>
</date>
<date date-type="received">
<day>20</day>
<month>7</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>7</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Rett syndrome (RTT), an X-linked dominant neurodevelopmental disorder in females, is caused mainly by de novo mutations in the methyl-CpG-binding protein 2 gene (<italic>MECP2</italic>). Rett patients present an apparently normal psychomotor development during the first 6 to 18 months of life. Thereafter, they show a short period of developmental stagnation followed by a rapid regression in language and motor development. In the present study, we performed a mutational analysis of the <italic>MECP2</italic> gene in 2 typical Rett syndrome patients and in 1 atypical Rett syndrome girl. The results showed the presence of 3 de novo point mutations in the C-terminal region: 2 novel mutations: c.1065C&gt;A (p.S355R) and c.1030C&gt;G (p.R344G) in the 2 typical Rett syndrome girls, but also the c.996C&gt;T (p.S332S) mutation first described in the atypical Rett syndrome patient.</p>
</abstract>
<kwd-group>
<kwd>Rett syndrome</kwd>
<kwd>p.S355R</kwd>
<kwd>p.R344G</kwd>
<kwd>p.S332S</kwd>
<kwd>
<italic>MECP2</italic> gene</kwd>
<kwd>C-terminal</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Rett syndrome (RTT; OMIM 312750), first described by the Austrian pediatrician Rett,<sup><xref ref-type="bibr" rid="bibr1-0883073811420496">1</xref></sup> is 1 of the leading causes of mental retardation and developmental regression in girls. Its prevalence is estimated to be from 1:10 000 to 1:15 000 females worldwide with most cases being sporadic.<sup><xref ref-type="bibr" rid="bibr2-0883073811420496">2</xref></sup> Patients with classical Rett syndrome show an apparently normal psychomotor development during the first 6 to 18 months of life. Thereafter, they enter a short period of developmental stagnation followed by a rapid regression in language and motor development. Purposeful hand use is often lost and replaced by repetitive, stereotypic movements. Additional symptoms include acquired microcephaly, gait ataxia/apraxia, seizures, and episodic apnea and/or hyperpnea.<sup><xref ref-type="bibr" rid="bibr3-0883073811420496">3</xref>,<xref ref-type="bibr" rid="bibr4-0883073811420496">4</xref></sup>
</p>
<p>Rett syndrome is an X-linked dominant disorder caused mainly by <italic>de novo</italic> mutations at methyl-CpG-binding protein 2 (<italic>MECP2</italic>) gene on chromosome Xq28.<sup><xref ref-type="bibr" rid="bibr5-0883073811420496">5</xref></sup>
<italic>MECP2</italic> gene encodes MeCP2 protein whose expression predominates in brain, fibroblast, and lymphoblast cells.<sup><xref ref-type="bibr" rid="bibr6-0883073811420496">6</xref></sup> This protein has 2 major functional domains: the methyl-binding domain (MBD), which binds specifically to DNA at methylated CpG’s, and a transcription repression domain (TRD) responsible for recruiting other proteins that mediated transcription repression.<sup><xref ref-type="bibr" rid="bibr7-0883073811420496">7</xref>,<xref ref-type="bibr" rid="bibr8-0883073811420496">8</xref></sup> In addition, a nuclear localization signal (NLS) is part of transcription repression domain (TRD) and it is important for translocation of newly synthesized MeCP2 from the cytoplasm to the nucleus.<sup><xref ref-type="bibr" rid="bibr9-0883073811420496">9</xref></sup> Between the MBD and the TRD domain a corepressor interacting region (CRIR) was defined.<sup><xref ref-type="bibr" rid="bibr10-0883073811420496">10</xref></sup>
</p>
<p>Mutations in <italic>MECP2</italic> were first reported in 1999<sup><xref ref-type="bibr" rid="bibr5-0883073811420496">5</xref></sup> and subsequent screening of Rett syndrome patients has shown that almost 90% to 95% of classical Rett syndrome have pathogenic mutations.<sup><xref ref-type="bibr" rid="bibr11-0883073811420496">11</xref>,<xref ref-type="bibr" rid="bibr12-0883073811420496">12</xref></sup> To date, over 200 individual nucleotide changes which cause pathogenic mutations have been described (RettBASE; mecp2.chw.edu.au and MeCP2.org.uk); however, the 8 most commonly occurring missense and nonsense mutations account for almost 70% of all mutations, and small deletions associated with a deletion hotspot in the C-terminal region of the MeCP2 protein account for an additional 9% of pathogenic mutations. Mutations are found throughout the gene, and more recently large deletions that delete whole exons have also been identified in a proportion of patients who were previously considered to be mutation negative, and are more commonly found in individuals with classical than atypical Rett syndrome cases.<sup><xref ref-type="bibr" rid="bibr13-0883073811420496">13</xref><xref ref-type="bibr" rid="bibr14-0883073811420496"/><xref ref-type="bibr" rid="bibr15-0883073811420496"/><xref ref-type="bibr" rid="bibr16-0883073811420496"/><xref ref-type="bibr" rid="bibr17-0883073811420496"/>–<xref ref-type="bibr" rid="bibr18-0883073811420496">18</xref></sup> On the other hand, pathogenic mutations involving exon 1 appear to be only rarely associated with Rett syndrome.<sup><xref ref-type="bibr" rid="bibr12-0883073811420496">12</xref>,<xref ref-type="bibr" rid="bibr17-0883073811420496">17</xref></sup>
</p>
<p>In the present study, we performed a mutational analysis of the <italic>MECP2</italic> gene in 2 typical Rett syndrome patients and in 1 atypical Rett syndrome girl. The results showed the presence of 3 de novo point mutations in the C-terminal region: 2 novel mutations: c.1065C&gt;A (S355R) and c.1030C&gt;G (R344G) in the 2 typical Rett syndrome girls, but also the c.996C&gt;T (S332S) mutation in the atypical Rett syndrome patient.</p>
<sec id="section1-0883073811420496">
<title>Materials and Methods</title>
<sec id="section2-0883073811420496">
<title>Patients</title>
<p>The 3 Rett syndrome patients studied (2 typical and 1 atypical) were collected from the Department of Child and Adolescent Neurology in the National Institute of Neurology of Tunis in Tunisia. The 3 patients described in this report fulfilled the clinical diagnostic criteria of classical Rett Syndrome.<sup><xref ref-type="bibr" rid="bibr3-0883073811420496">3</xref></sup>
</p>
<p>The 2 typical Rett syndrome patients showed a psychomotor regression, mental delay, and stereotypic hand movements. The atypical Rett syndrome patient was a 12-year-old girl born after an uncomplicated pregnancy and normal vaginal delivery from healthy nonconsanguineous parents. Family history was negative and her birth weight was 3350 g. Perinatal and neonatal periods were without any serious problem. She developed the first seizure at the age of 2 months, and she showed psychomotor regression at the age of 6 months. She started standing without support at the age of 18 months, and she was unable to speak. In addition, she had an autistic comportment with stereotypic movements.</p>
<p>Blood samples were obtained from the patients and her parents after informed consent. For each patient, clinical history interviews, clinical examination, and a brain computed tomography scan were performed.</p>
<p>In addition, 50 Tunisian healthy individuals from the same ethnocultural group were tested as controls. These controls should have no personal or family history of neurological disorder.</p>
</sec>
<sec id="section3-0883073811420496">
<title>Methods</title>
<sec id="section4-0883073811420496">
<title>DNA Extraction</title>
<p>After getting informed consent from all the participating family’s members, total DNA was extracted from peripheral blood using standard phenol-chloroform procedures.<sup><xref ref-type="bibr" rid="bibr19-0883073811420496">19</xref></sup>
</p>
</sec>
<sec id="section5-0883073811420496">
<title>Polymerase Chain Reaction Amplification and Sequencing of the MECP2 Gene</title>
<p>The 4 exons of <italic>MECP2</italic> gene with their flanking exon–intron boundaries were amplified by polymerase chain reaction (PCR) and sequenced as previously described.<sup><xref ref-type="bibr" rid="bibr12-0883073811420496">12</xref>,<xref ref-type="bibr" rid="bibr20-0883073811420496">20</xref>,<xref ref-type="bibr" rid="bibr21-0883073811420496">21</xref></sup>
</p>
</sec>
<sec id="section6-0883073811420496">
<title>Bioinformatic Tools</title>
<p>The blast homology searches were performed using the blast2seq program available at the National Center for Biotechnology Information (NCBI) Web site <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">http://www.ncbi.nlm.nih.gov/</ext-link>. The sequence alignment was performed using the blat program available at the Genome Browser Web site (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>
<bold>)</bold>.</p>
</sec>
</sec>
</sec>
<sec id="section7-0883073811420496">
<title>Results</title>
<p>The sequencing analysis of the 4 exons of the <italic>MECP2</italic> gene and their flanking exon–intron boundaries in the 2 studied Tunisian patients with classical Rett syndrome showed the presence of 2 undescribed heterozygous transversions in the C-terminal segment: c.1065C&gt;A (p.S355R) and c.1030C&gt;G (p.R344G).</p>
<p>The c.1065C&gt;A mutation (<xref ref-type="fig" rid="fig1-0883073811420496">Figure 1A</xref>) is a transversion, which substitutes the conserved serine residue by an arginine at the amino acid 355 (p.S355R) (<xref ref-type="fig" rid="fig1-0883073811420496">Figure 1B</xref>). It was absent in 100 Tunisian control chromosomes and it was <italic>de novo</italic> mutation since it was absent in the patient’s parents.</p>
<fig id="fig1-0883073811420496" position="float">
<label>Figure 1.</label>
<caption>
<p>(A) Sequence chromatograms showing the presence of the heterozygous c.1065C&gt;A (p.S355R) mutation in the C-terminal region of the <italic>MECP2</italic> gene and its absence in a control. (B) Alignment of the MeCP2 protein in different species showing the conservation of the amino acid S355.</p>
</caption>
<graphic alternate-form-of="fig1-0883073811420496" xlink:href="10.1177_0883073811420496-fig1.tif"/>
</fig>
<p>In addition, we found a heterozygous variant (c.996C&gt;T) in the studied atypical Rett syndrome patient. It was absent in the patient’s parents and in 100 Tunisian control chromosomes. This variation did not change the amino acid (p.S332S) and can be considered as a silent mutation. This <italic>de novo</italic> p.S332S mutation affects also the C-terminal segment of the MeCP2 protein (<xref ref-type="fig" rid="fig3-0883073811420496">Figure 3</xref>).</p>
<fig id="fig2-0883073811420496" position="float">
<label>Figure 2.</label>
<caption>
<p>(A) Sequence chromatograms showing the presence of the heterozygous c.1030C&gt;G (p.R344G) mutation in the C-terminal region of the <italic>MECP2</italic> gene and its absence in a control. (B) Alignment of the MeCP2 protein in different species showing the conservation of the amino acid R344.</p>
</caption>
<graphic alternate-form-of="fig2-0883073811420496" xlink:href="10.1177_0883073811420496-fig2.tif"/>
</fig>
<fig id="fig3-0883073811420496" position="float">
<label>Figure 3.</label>
<caption>
<p>Sequence chromatograms showing the presence of the heterozygous c.996C&gt;T (p.S332S) mutation in the C-terminal region of the <italic>MECP2</italic> gene and its absence in a control.</p>
</caption>
<graphic alternate-form-of="fig3-0883073811420496" xlink:href="10.1177_0883073811420496-fig3.tif"/>
</fig>
</sec>
<sec id="section8-0883073811420496">
<title>Discussion</title>
<p>In this report, we performed a mutational analysis of the <italic>MECP2</italic> gene and we identified 3 heterozygous <italic>de novo</italic> point mutations affecting the C-terminal segment in 3 Tunisian Rett syndrome patients.</p>
<p>The C-terminal region of the MeCP2 protein was described as a deletion hotspot. In fact, the small deletions identified account for 9% of pathogenic mutations in Rett syndrome.<sup><xref ref-type="bibr" rid="bibr13-0883073811420496">13</xref><xref ref-type="bibr" rid="bibr14-0883073811420496"/><xref ref-type="bibr" rid="bibr15-0883073811420496"/><xref ref-type="bibr" rid="bibr16-0883073811420496"/><xref ref-type="bibr" rid="bibr17-0883073811420496"/>–<xref ref-type="bibr" rid="bibr18-0883073811420496">18</xref></sup> However, point mutations were also identified in C-terminal region of the MeCP2 protein.<sup><xref ref-type="bibr" rid="bibr22-0883073811420496">22</xref><xref ref-type="bibr" rid="bibr23-0883073811420496"/><xref ref-type="bibr" rid="bibr24-0883073811420496"/><xref ref-type="bibr" rid="bibr25-0883073811420496"/>–<xref ref-type="bibr" rid="bibr26-0883073811420496">26</xref></sup>
</p>
<p>The first studied patient with classical Rett syndrome had a novel heterozygous c.1065C&gt;A (p.S355R) mutation which changes the serine residue by an arginine at the conserved amino acid 355 of MeCP2 protein (<xref ref-type="fig" rid="fig1-0883073811420496">Figure 1B</xref>). The same S355 residue was mutated in another Rett syndrome patient, but it was a silent mutation since it the c.1065C&gt;T transition (p.S355S) does not change the amino acid.<sup><xref ref-type="bibr" rid="bibr25-0883073811420496">25</xref></sup>
</p>
<p>We also detected another novel transversion in the second patient with classical Rett syndrome. It was an undescribed heterozygous point mutation which arises <italic>de novo</italic> and substitutes the conserved arginine at position 344 by a glycine residue (p.R344G) (<xref ref-type="fig" rid="fig2-0883073811420496">Figure 2B</xref>).</p>
<p>We noticed that the substitution of the hydrophilic R344 by the hydrophobic glycine can affect the electrostatic potential of this protein region. Another missense mutation in the same R344 residue was identified in Rett syndrome patient, but in this case, the transition c.1030C&gt;T (p.R344W) changed the arginine by a tryptophan residue.<sup><xref ref-type="bibr" rid="bibr26-0883073811420496">26</xref></sup>
</p>
<p>Furthermore, we detected the c.996C&gt;T (p.S332S) variant in the atypical Rett syndrome patient (<xref ref-type="fig" rid="fig3-0883073811420496">Figure 3</xref>). This silent substitution was recently reported as a polymorphism in a Canadian child with autism spectrum disorder.<sup><xref ref-type="bibr" rid="bibr24-0883073811420496">24</xref></sup> Therefore, this variant could be responsible for the clinical problems of the studied atypical Rett syndrome in association with an eventual other mutation or polymorphisms in <italic>MECP2</italic> or other genes such as <italic>CDKL5</italic> (cyclin-dependent kinase-like 5) and <italic>FOXG1</italic> (Forkhead box protein G1).</p>
<p>The c.1030C&gt;G transversion (<xref ref-type="fig" rid="fig2-0883073811420496">Figure 2B</xref>) affects a conserved amino acid (<xref ref-type="fig" rid="fig2-0883073811420496">Figure 2B</xref>) and changes the arginine at position 344 by a glycine residue (p.R344G). It was also not found in 100 Tunisian control chromosomes and in the patient’s parents suggesting that it was a <italic>de novo</italic> mutation.</p>
<p>In conclusion, this study reports a mutational analysis of the <italic>MECP2</italic> coding regions in 3 Rett syndrome patients. The results showed the presence of 3 <italic>de novo</italic> point mutations in the C-terminal region of MeCP2 protein. In fact, we detected 2 novel mutations c.1065C&gt;A (p.S355R) and c.1030C&gt;G (p.R344G) in 2 Tunisian patients with typical Rett syndrome and 1 mutation c.996C&gt;T (p.S332S) first described in Tunisian atypical Rett syndrome patient.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was performed in the Laboratory of Human Molecular Genetics in the faculty of Medicine of Sfax in Tunisia with the collaboration of the Department of Child and Adolescent Neurology in the National Institute of Neurology of Tunis in Tunisia. We thank the patients and their families for their cooperation in the present study. This work was supported by the Ministry of Higher Education and Scientific Research in Tunisia. We extend our thanks to Mr Jamil Jaoua, Coordinator of the English Unit at the Sfax Faculty of Science, for having proofread this paper.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-0883073811420496">
<p>NF-K performed the molecular genetic studies and drafted the manuscript. AR carried out the clinical explorations. RG performed the molecular genetic studies. EM-R wrote the first draft of the manuscript. NB carried out the clinical explorations. NG-K provided the clinical explorations, supervised and conceived the clinical part of the manuscript. FF supervised and conceived the molecular genetic studies and drafted the manuscript. All authors read and approved the final manuscript.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811420496">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811420496">
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="other" id="fn4-0883073811420496">
<p>The present study was performed with ethical approval and informed consent procedures.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811420496">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rett</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Uberein eigenartiges hirnatrophisches Syndrom bei Hyperammonemie im Kindesalter</article-title>. <source>Wien Med Wochenschr</source>. <year>1966</year>;<volume>116</volume>:<fpage>723</fpage>–<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811420496">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurvick</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>de Klerk</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bower</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome in Australia: a review of the epidemiology</article-title>. <source>J Pediatr</source>. <year>2006</year>;<volume>148</volume>:<fpage>347</fpage>–<lpage>352</lpage>.</citation>
</ref>
<ref id="bibr3-0883073811420496">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagberg</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Skjeldal</surname>
<given-names>O.</given-names>
</name>
</person-group> <article-title>An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden, Germany, 11 September 2001</article-title>. <source>Eur J Paediatr Neurol</source>. <year>2002</year>;<volume>6</volume>:<fpage>293</fpage>–<lpage>297</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811420496">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neul</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>DG</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome: revised diagnostic criteria and nomenclature</article-title>. <source>Ann Neurol</source>. <year>2010</year>;<volume>68</volume>:<fpage>944</fpage>–<lpage>950</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811420496">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source>Nat Genet</source>. <year>1999</year>;<volume>23</volume>:<fpage>185</fpage>–<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811420496">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirianni</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Naidu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28</article-title>. <source>Am J Hum Genet</source>. <year>1998</year>;<volume>63</volume>:<fpage>1552</fpage>–<lpage>1558</lpage>.</citation>
</ref>
<ref id="bibr7-0883073811420496">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stancheva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Van Den Veyver</surname>
<given-names>IB</given-names>
</name>
<etal/>
</person-group>. <article-title>A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos</article-title>. <source>Mol Cell</source>. <year>2003</year>;<volume>12</volume>:<fpage>425</fpage>–<lpage>435</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811420496">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harikrishnan</surname>
<given-names>KN</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>MZ</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>EK</given-names>
</name>
<etal/>
</person-group>. <article-title>Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing</article-title>. <source>Nat Genet</source>. <year>2005</year>;<volume>37</volume>:<fpage>254</fpage>–<lpage>264</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811420496">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>The biological functions of the methyl- CpG-binding protein MeCP2 and its implication in Rett syndrome</article-title>. <source>Brain Dev</source>. <year>2001</year>;<volume>23</volume>(<issue>Suppl 1</issue>):<fpage>S32</fpage>–<lpage>S27</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811420496">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>XH</given-names>
</name>
<etal/>
</person-group>. <article-title>MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome</article-title>. <source>J Hum Genet</source>. <year>2007</year>;<volume>52</volume>:<fpage>38</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr11-0883073811420496">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hanefeld</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meins</surname>
<given-names>M.</given-names>
</name>
</person-group> <article-title>Mutation spectrum in patients with Rett syndrome in the German population: evidence of hot spot regions</article-title>. <source>Hum Mutat</source>. <year>2001</year>;<volume>17</volume>:<fpage>183</fpage>–<lpage>190</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811420496">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome</article-title>. <source>J Med Genet</source>. <year>2005</year>;<volume>42</volume>:<fpage>e15</fpage>.</citation>
</ref>
<ref id="bibr13-0883073811420496">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ariani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pescucci</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication</article-title>. <source>Hum Mutat</source>. <year>2004</year>;<volume>24</volume>:<fpage>172</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811420496">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Junemann</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Whatley</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome</article-title>. <source>Hum Mutat</source>. <year>2004</year>;<volume>23</volume>:<fpage>234</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr15-0883073811420496">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Archer</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Whatley</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett Syndrome</article-title>. <source>J Med Genet</source>. <year>2006</year>;<volume>43</volume>:<fpage>451</fpage>–<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr16-0883073811420496">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ohlenbusch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brendel</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation analysis of the HDAC 1, 2, 8 and CDKL5 genes in Rett syndrome patients without mutations in MECP2</article-title>. <source>Am J Med Genet A</source>. <year>2005</year>;<volume>137</volume>:<fpage>136</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr17-0883073811420496">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravn</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Skjeldal</surname>
<given-names>OH</given-names>
</name>
<etal/>
</person-group>. <article-title>Large genomic rearrangements in MECP2</article-title>. <source>Hum Mutat</source>. <year>2005</year>;<volume>25</volume>:<fpage>324</fpage>.</citation>
</ref>
<ref id="bibr18-0883073811420496">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shibayama</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by robust dosage PCR (RD-PCR)</article-title>. <source>Hum Mutat</source>. <year>2005</year>;<volume>25</volume>:<fpage>505</fpage>.</citation>
</ref>
<ref id="bibr19-0883073811420496">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewin</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Stewart-Haynes</surname>
<given-names>JA.</given-names>
</name>
</person-group> <article-title>A simple method for DNA extraction from leukocytes for use in PCR</article-title>. <source>Biotechniques</source>. <year>1992</year>;<volume>13</volume>:<fpage>522</fpage>–<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr20-0883073811420496">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fendri-Kriaa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Abdelkafi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Rebeh</surname>
<given-names>IB</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel MECP2 gene mutation in a Tunisian patient with Rett syndrome</article-title>. <source>Genet Test Mol Biomarkers</source>. <year>2009</year>;<volume>13</volume>:<fpage>109</fpage>–<lpage>113</lpage>.</citation>
</ref>
<ref id="bibr21-0883073811420496">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fendri-Kriaa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hsairi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kifagi</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>The Tunisian network on mental retardation study. A case of a Tunisian Rett patient with a novel double-mutation of the MECP2 gene</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2011</year>;<volume>409</volume>:<fpage>270</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr22-0883073811420496">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Bona</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zappella</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Preserved speech variant is allelic of classic Rett syndrome</article-title>. <source>Eur J Hum Genet</source>. <year>2000</year>;<volume>8</volume>:<fpage>325</fpage>–<lpage>330</lpage>.</citation>
</ref>
<ref id="bibr23-0883073811420496">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>BH</given-names>
</name>
<etal/>
</person-group>. <article-title>Diagnostic mutational analysis of MECP2 in Korean patients with Rett syndrome</article-title>. <source>Exp Mol Med</source>. <year>2006</year>;<volume>38</volume>:<fpage>119</fpage>–<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr24-0883073811420496">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<etal/>
</person-group>. <article-title>Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia</article-title>. <source>Mol Psychiatry</source>. <year>2011</year>;<volume>16</volume>:<fpage>867</fpage>–<lpage>880</lpage>.</citation>
</ref>
<ref id="bibr25-0883073811420496">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bunyan</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>DO.</given-names>
</name>
</person-group> <article-title>Multiple de novo mutations in the MECP2 gene</article-title>. <source>Genet Test</source>. <year>2008</year>;<volume>12</volume>:<fpage>373</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr26-0883073811420496">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laccone</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zoll</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huppke</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution</article-title>. <source>J Med Genet</source>. <year>2002</year>;<volume>39</volume>:<fpage>586</fpage>–<lpage>568</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>